Increased responses to adenosine in isolated left atria from streptozotocin-diabetic rats: Evidence for the involvement of hypothyroidism

Journal of Cardiovascular Pharmacology

Volumn 29, Issue 2, 1997, Pages 174-179

  Gür, Serap ^a   Ari, Nuray ^a   Öztürk, Yusuf ^b  

^a ANKARA UNIVERSITY   (Turkey)

^b ANADOLU UNIVERSITY   (Turkey)

Author keywords

Adenosine; Diabetes mellitus; Hypothyroidism; Insulin; Triiodothyronine

Indexed keywords

ADENOSINE; ADENOSINE RECEPTOR; INSULIN; ISOPRENALINE; LIOTHYRONINE; PROPYLTHIOURACIL; STREPTOZOCIN; THYROID HORMONE;

ADRENERGIC RECEPTOR BLOCKING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; HEART LEFT ATRIUM; HYPOTHYROIDISM; INOTROPISM; INTRAVENOUS DRUG ADMINISTRATION; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; SUBCUTANEOUS DRUG ADMINISTRATION;

ADENOSINE; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPOTHYROIDISM; MALE; MYOCARDIAL CONTRACTION; RATS; STREPTOZOCIN;

EID: 0343247716     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199702000-00004     Document Type: Article

References (46)

1. Fein FS, Sonnenblick EH. Diabetic cardiomyopathy. Prog Cardiovasc Dis 1985;27:255-71.
2. Cruickshanks KJ, Orchard TJ, Becker DJ. The cardiovascular risk profile of adolescents' insulin-dependent diabetes mellitus. Diabetes Care 1985;8:118-24.
3. Kessler I. Mortality experience of diabetic patients. Am J Med 1971;51:715-24.
4. Kannel WB, McGee DL. Diabetes and cardiovascular risk factors: the Framingham study. Circulation 1979;59:8-13.
5. Garber DW, Neely JR. Decreased myocardial function and myosin ATPase in hearts from diabetic rats. Am J Physiol 1983;244: H586-91.
6. Penpargkul S, Schaible T, Ypitsoi T, Scheuer J. The effect of diabetes on performance and metabolism of rat hearts. Circ Res 1980;47:911-21.
7. Savarase JJ, Berkowitz BA. β-Adrenergic receptor decreases in diabetic hearts. Life Sci 1979;25:2075-8.
8. Ramanadham S, Tenner TE Jr. Alterations in cardiac performance in experimentally induced diabetes. Pharmacology 1983;27:130-9.
9. Karasu Ç, Öztürk Y, Altan N, Yildizoǧlu-Ari N, Ikizler C, Altan VM. Thyroid hormones mediated effect of insulin on alloxan diabetic rat atria. Gen Pharmacol 1990;21:735-40.
10. Öztürk Y, Yildizoǧlu-Ari N, Altan VM, Özçelikay AT. Effect of insulin on the decreased β-adrenergic responses of duodenum and atrium isolated from streptozotocin diabetic rats. Gen Pharmacol 1993;24:217-23.
11. Özüari A, Öztürk Y, Yildizoǧlu-Ari N, Özçelikay AT, Altan VM. The effects of glyburide and insulin on the cardiac performance in rats with non-insulin-dependent diabetes mellitus. Gen Pharmacol 1993;24:165-9.
12. 1-adrenergic responsiveness of alloxan diabetic rat atria: effects of insulin therapy and thyroidectomy. Gen Pharmacol 1994;25:559-64.
13. Özçelikay AT, Yildizoǧlu-Ari N, Özüari A, Öztürk Y, Altan VM. The effect of vanadate on alloxan-diabetic rat atria. Diabetes Res Clin Pract 1993;19:189-94.
14. 4. Am J Physiol 1983;244:H592-8.
15. 3) production in diabetic patients. Metabolism 1979;28:333-8.
16. Sundaresan PR, Sharma VK, Gingold SI, Banerjee SP. Decreased β-adrenergic receptors in rat heart in streptozotocin-induced diabetes: role of thyroid hormones. Endocrinology 1984;114:1358-63.
17. de Gubareff T, Sleator W. Effects of caffeine on mammalian atrial muscle, and its interaction with adenosine and calcium. J Pharmacol Exp Ther 1965;148:202-14.
18. Wilson ANA, Broadley KJ. Analysis of the direct and indirect effects of adenosine on atrial and ventricular cardiac muscle. Can J Physiol Pharmacol 1989;67:294-303.
19. Burnstock G, Meghji P. The effect of adenyl compounds on the rat heart. Br J Pharmacol 1983;79:211-8.
20. Böhm M, Brückner R, Neumann J, Schmitz W, Scholz H, Starbatty J. Role of guanine nucleotide-binding protein in the regulation by adenosine of cardiac potassium conductance and force of contraction: evaluation with pertussis toxin. Naunyn-Schmiedebergs Arch Pharmacol 1986;332:403-5.
21. Endoh M, Maruyama M, Taira NJ. Modificalion of islet-activating protein of direct and indirect inhibitory actions of adenosine on rat atrial contraction in relation to cyclic nucleotide metabolism. J Cardiovasc Pharmacol 1983;5:131-42.
22. Brückner R, Fenner A, Meyer W, Nobis T-M, Schmitz W, Scholz H. Cardiac effects of adenosine and adenosine analogs in guinea-pig atrial and ventricular preparations: evidence against a role of cyclic AMP and cyclic GMP. J Pharmacol Exp Ther 1985;234:766-74.
23. Belardinelli L, Isenberg G. Isolated atrial myocytes: adenosine and acetylcholine increase potassium conductance. Am J Physiol 1983;244:H734-7.
24. Jochem G, Nawarath H. Adenosine activates a potassium conductance in guinea-pig atrial heart muscle. Experientia 1983;39:1347-9.
25. Böhm M, Brückner R, Hackbarth I, et al. Adenosine inhibition of catecholamine-induced increase in force of contraction in guinea-pig atrial and ventricular heart preparations: evidence against a cyclic AMP- and cyclic GMP-dependent effect. J Pharmacol Exp Ther 1984;230:483-92.
26. Rockoff JB, Dobson JG. Inhibition by adenosine of catecholamine-induced increase in rat atrial contractility. Am J Physiol 1980;239: H365-70.
27. Linden J, Hollen CE, Patel A. The mechanism by which adenosine and cholinergic agents reduce contractility in the rat myocardium. Circ Res 1985;56:728-35.
28. Durante W, Sunahara FA, Sen AK. Alterations in atrial reactivity in a strain of spontaneously diabetic rats. Br J Pharmacol 1989;97: 1137-44.
29. Li XJ. Supersensitivity of isolated atria from diabetic rats to adenosine and methacholine: modulation by pertussis toxin. J Pharm Pharmacol 1992;44:142-4.
30. Gür S, Öztürk Y. The negative inotropic effect of adenosine in left atria of insulin-dependent, non-insulin dependent diabetic and hypothyroid rats [Abstract], Drug Dev Res 1994;31:275.
31. Britton KE, Quinn V, Brown BL, Ekins RP. A strategy for thyroid function tests. Br Med. J 1975;3:350-2.
32. Fales FW, Russel JA, Fain JN. Some applications and limitations of the enzymatic, reducing (Somogyi) and anthrone methods for estimating sugars. Clin Chem 1961;7:389-95.
33. x′ values in analysis of pharmacodynamics. Arch Int Pharmacodyn Ther 1957;110:275-99.
34. Ariëns EJ, Simmonis AM. Drug receptor interaction: interaction of one or more drugs with a receptor system. In: Ariëns EJ, ed Molecular pharmacology. Vol 8. London: Academic Press, 1964:119-286.
35. Finney DJ, eds. Statistical methods in biological assay. London: Griffin, 1981.
36. Wichelhaus A, Russ M, Petersen S, Eckel J. G protein expression and adenylate cyclase regulation in ventricular cardiomyocytes from STZ-diabetic rats. Am J Physiol 1994;267:H548-55.
37. Ohisalo JJ, Stouffer JE. Adenosine, thyroid status and regulation of lipolysis. Biochem J 1979;178:249-51.
38. Woodward JA, Saggerson ED. Effect of adenosine deaminase, N6-phenylisopropyladenosine and hypothyroidism on the responsiveness of rat brown adipocytes to noradrenaline. Biochem J 1986; 238:395-403.
39. Jamal Z, Saggerson ED. Enzymes involved m adenosine metabolism in rat white and brown adipocytes: effect of streptozotocin-diabetes, hypothyroidism, age and sex differences. Biochem J 1987; 245:881-6.
40. Belardinelli L, Isenberg G. Isolated atrial myocytes: adenosine and acetylcholine increase potassium conductance. Am J Physiol 1983;44:H734-7.
41. Cerbai E, Klöckner U, Isenberg G. Ca-antagonistic effects of adenosine in guinea-pig atrial cells. Am J Physiol 1988;255:H872-8.
42. Kim D, Smith TW, Marsh JD. Effect of thyroid hormone on slow calcium channel function in cultured chick ventricular cells. J Clin Invest 1987;80:88-94.
43. + depolarization. Biochem J 1990;268:563-9.
44. Hawthorn MH, Gengo P, Wei X-Y, et al. Effect of thyroid status on β-adrenoceptors and calcium channels in rat cardiac and vascular tissue. Naunyn-Schmiedebergs Arch Pharmacol 1988;337:539-44.
45. Warner EL, Gallasso F, Thompson CI, Belloni FL. Vasodilative and anti-adrenergic effects of adenosine in diabetic rat hearts. Can J Physiol Pharmacol 1992;70:13-9.
46. Romano FD, Kopp SJ, Daar JT, Smith CA. The antiadrenergic effect of cyclopentyladenosine on myocardial contractility is reduced in vivo in diabetic rats. Can J Physiol Pharmacol 1994;72:1245-55.